Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002226
Filing Date
2015-11-04
Accepted
2015-11-04 13:02:41
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tlog-20150930x10q.htm 10-Q 1419532
2 EX-31.1 tlog-20150930ex311666052.htm EX-31.1 20359
3 EX-31.2 tlog-20150930ex31263ee16.htm EX-31.2 20062
4 EX-32.1 tlog-20150930ex3217fb70a.htm EX-32.1 9957
5 EX-32.2 tlog-20150930ex3224cd280.htm EX-32.2 9518
  Complete submission text file 0001558370-15-002226.txt   6526752

Data Files

Seq Description Document Type Size
6 EX-101.INS tlog-20150930.xml EX-101.INS 1632674
7 EX-101.SCH tlog-20150930.xsd EX-101.SCH 35238
8 EX-101.CAL tlog-20150930_cal.xml EX-101.CAL 47763
9 EX-101.DEF tlog-20150930_def.xml EX-101.DEF 159044
10 EX-101.LAB tlog-20150930_lab.xml EX-101.LAB 421891
11 EX-101.PRE tlog-20150930_pre.xml EX-101.PRE 281384
Mailing Address 343 PHOENIXVILLE PIKE MALVERN PA 19355
Business Address 343 PHOENIXVILLE PIKE MALVERN PA 19355 610-889-9900
TETRALOGIC PHARMACEUTICALS CORP (Filer) CIK: 0001361248 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36208 | Film No.: 151196229
SIC: 2834 Pharmaceutical Preparations